Vanderbilt Research Trending

Researchers at Vanderbilt University Medical Center have discovered a key mechanism that explains how compounds they’re developing can suppress schizophrenia-like symptoms without side effects in mice.

A research team led by structural biologists from Vanderbilt University has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) “gender gap.”

As part of the national Cancer Moonshot initiative, a Blue Ribbon Panel (BRP) of cancer leaders, including four from Vanderbilt-Ingram Cancer Center, has delivered a series of recommendations to accelerate the pace of cancer prevention efforts and scientific discovery.

A consortium led by Vanderbilt University Medical Center (VUMC) researchers has received funding as it makes plans for a multicenter trial that could determine whether deep brain stimulation (DBS) slows the progression of Parkinson’s disease in early-stage patients.

Researchers at Vanderbilt University Medical Center and Vanderbilt University have received a $1.9 million grant from the National Institutes of Health (NIH) to support research to restore vision through regeneration of the retina.

Vanderbilt University researchers from diverse scientific disciplines are joining forces to help crack the stubborn mysteries of addiction through the new Vanderbilt Center for Addiction Research.

The National Institutes of Health (NIH) has awarded a major renewal grant to continue the National Research Resource for Imaging Mass Spectrometry at Vanderbilt University School of Medicine.